In vivo histopathologic comparison of the acute injury following treatment with five fractional ablative laser devices

Jordan P. Farkas, James A. Richardson, Clint F. Burrus, John E. Hoopman, Spencer A. Brown, Jeffrey M. Kenkel

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Both erbium (Er:YAG) and carbon dioxide (CO2) devices are commonly-used, efficient laser systems for aggressive skin resurfacing procedures. The devices each have different adjustable parameters (density, spot size, number of pulses, pattern, etc) and utilize variable energy capabilities to tailor individual treatments depending on the skin pathology and goals of treatment. Overall, the consensus has been that multiple-pass erbium treatments needed for efficacious wrinkle reduction had similar downtime and comorbidity to the traditional CO2 treatments. Unfortunately, there were limited data comparing the histological differences and changes throughout the wound-healing process over time between the two treatment methods. Objectives: The authors compare the difference in injury following treatment with five novel fractional ablative laser systems in vivo. Differences in damage pattern, treatment depth, and degree of surrounding cellular injury following treatment with each device at common clinical settings are evaluated in a side-by-side histopathologic comparison. Methods: Prior to planned excisional surgery, the panni of 20 abdominoplasty patients were treated with five novel ablative fractional carbon dioxide or Er:YAG laser systems at various clinical parameters, in accordance with the manufacturers' treatment guidelines. After tissue removal two to four hours later, the skin was biopsied and processed for histopathologic evaluation. Specimens were stained with hematoxylin and eosin, along with a terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay, to highlight the degree of irreversible cellular injury. Results: The acute damage profile differed between the fractional Er:YAG and CO2 devices with respect to depth of penetration and extension of coagulation surrounding the microcolumns. The damage pattern was dependent on the parameters set with each device (eg, fluence, pulses, density, pulse width). The TUNEL-stained sections demonstrated more collateral cellular injury surrounding the ablated columns with the CO2 devices than with the Er:YAG systems. Conclusions: Following treatment with the fractional Er:YAG and CO2 devices, deep tissue injury with various coagulative and ablative properties was observed, and it was confirmed that carbon dioxide and erbium devices result in different patterns of injury. As such, each may be better suited for different clinical situations. It is important for practitioners to understand the limitations of a specific device, as well as the tissue injury following a given treatment pattern or protocol, to appropriately tailor their treatment algorithm for a given patient. This extensive histopathologic evaluation of the acute characterization of injury across devices is helpful in clarifying the differences/similarities in laser-tissue interaction following treatment in an in vivo human model.

Original languageEnglish (US)
Pages (from-to)457-464
Number of pages8
JournalAesthetic Surgery Journal
Volume30
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Lasers
Equipment and Supplies
Wounds and Injuries
Erbium
Therapeutics
Carbon Dioxide
Skin
Abdominoplasty
DNA Nucleotidylexotransferase
Solid-State Lasers
Hematoxylin
Eosine Yellowish-(YS)
Transferases
Wound Healing
Comorbidity
Guidelines
Pathology

Keywords

  • ablative
  • fractional
  • histology
  • injury
  • laser

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

In vivo histopathologic comparison of the acute injury following treatment with five fractional ablative laser devices. / Farkas, Jordan P.; Richardson, James A.; Burrus, Clint F.; Hoopman, John E.; Brown, Spencer A.; Kenkel, Jeffrey M.

In: Aesthetic Surgery Journal, Vol. 30, No. 3, 2010, p. 457-464.

Research output: Contribution to journalArticle

@article{10bb95e9377b491596fb6770d6b73d1c,
title = "In vivo histopathologic comparison of the acute injury following treatment with five fractional ablative laser devices",
abstract = "Background: Both erbium (Er:YAG) and carbon dioxide (CO2) devices are commonly-used, efficient laser systems for aggressive skin resurfacing procedures. The devices each have different adjustable parameters (density, spot size, number of pulses, pattern, etc) and utilize variable energy capabilities to tailor individual treatments depending on the skin pathology and goals of treatment. Overall, the consensus has been that multiple-pass erbium treatments needed for efficacious wrinkle reduction had similar downtime and comorbidity to the traditional CO2 treatments. Unfortunately, there were limited data comparing the histological differences and changes throughout the wound-healing process over time between the two treatment methods. Objectives: The authors compare the difference in injury following treatment with five novel fractional ablative laser systems in vivo. Differences in damage pattern, treatment depth, and degree of surrounding cellular injury following treatment with each device at common clinical settings are evaluated in a side-by-side histopathologic comparison. Methods: Prior to planned excisional surgery, the panni of 20 abdominoplasty patients were treated with five novel ablative fractional carbon dioxide or Er:YAG laser systems at various clinical parameters, in accordance with the manufacturers' treatment guidelines. After tissue removal two to four hours later, the skin was biopsied and processed for histopathologic evaluation. Specimens were stained with hematoxylin and eosin, along with a terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay, to highlight the degree of irreversible cellular injury. Results: The acute damage profile differed between the fractional Er:YAG and CO2 devices with respect to depth of penetration and extension of coagulation surrounding the microcolumns. The damage pattern was dependent on the parameters set with each device (eg, fluence, pulses, density, pulse width). The TUNEL-stained sections demonstrated more collateral cellular injury surrounding the ablated columns with the CO2 devices than with the Er:YAG systems. Conclusions: Following treatment with the fractional Er:YAG and CO2 devices, deep tissue injury with various coagulative and ablative properties was observed, and it was confirmed that carbon dioxide and erbium devices result in different patterns of injury. As such, each may be better suited for different clinical situations. It is important for practitioners to understand the limitations of a specific device, as well as the tissue injury following a given treatment pattern or protocol, to appropriately tailor their treatment algorithm for a given patient. This extensive histopathologic evaluation of the acute characterization of injury across devices is helpful in clarifying the differences/similarities in laser-tissue interaction following treatment in an in vivo human model.",
keywords = "ablative, fractional, histology, injury, laser",
author = "Farkas, {Jordan P.} and Richardson, {James A.} and Burrus, {Clint F.} and Hoopman, {John E.} and Brown, {Spencer A.} and Kenkel, {Jeffrey M.}",
year = "2010",
doi = "10.1177/1090820X10373060",
language = "English (US)",
volume = "30",
pages = "457--464",
journal = "Aesthetic Surgery Journal",
issn = "1090-820X",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - In vivo histopathologic comparison of the acute injury following treatment with five fractional ablative laser devices

AU - Farkas, Jordan P.

AU - Richardson, James A.

AU - Burrus, Clint F.

AU - Hoopman, John E.

AU - Brown, Spencer A.

AU - Kenkel, Jeffrey M.

PY - 2010

Y1 - 2010

N2 - Background: Both erbium (Er:YAG) and carbon dioxide (CO2) devices are commonly-used, efficient laser systems for aggressive skin resurfacing procedures. The devices each have different adjustable parameters (density, spot size, number of pulses, pattern, etc) and utilize variable energy capabilities to tailor individual treatments depending on the skin pathology and goals of treatment. Overall, the consensus has been that multiple-pass erbium treatments needed for efficacious wrinkle reduction had similar downtime and comorbidity to the traditional CO2 treatments. Unfortunately, there were limited data comparing the histological differences and changes throughout the wound-healing process over time between the two treatment methods. Objectives: The authors compare the difference in injury following treatment with five novel fractional ablative laser systems in vivo. Differences in damage pattern, treatment depth, and degree of surrounding cellular injury following treatment with each device at common clinical settings are evaluated in a side-by-side histopathologic comparison. Methods: Prior to planned excisional surgery, the panni of 20 abdominoplasty patients were treated with five novel ablative fractional carbon dioxide or Er:YAG laser systems at various clinical parameters, in accordance with the manufacturers' treatment guidelines. After tissue removal two to four hours later, the skin was biopsied and processed for histopathologic evaluation. Specimens were stained with hematoxylin and eosin, along with a terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay, to highlight the degree of irreversible cellular injury. Results: The acute damage profile differed between the fractional Er:YAG and CO2 devices with respect to depth of penetration and extension of coagulation surrounding the microcolumns. The damage pattern was dependent on the parameters set with each device (eg, fluence, pulses, density, pulse width). The TUNEL-stained sections demonstrated more collateral cellular injury surrounding the ablated columns with the CO2 devices than with the Er:YAG systems. Conclusions: Following treatment with the fractional Er:YAG and CO2 devices, deep tissue injury with various coagulative and ablative properties was observed, and it was confirmed that carbon dioxide and erbium devices result in different patterns of injury. As such, each may be better suited for different clinical situations. It is important for practitioners to understand the limitations of a specific device, as well as the tissue injury following a given treatment pattern or protocol, to appropriately tailor their treatment algorithm for a given patient. This extensive histopathologic evaluation of the acute characterization of injury across devices is helpful in clarifying the differences/similarities in laser-tissue interaction following treatment in an in vivo human model.

AB - Background: Both erbium (Er:YAG) and carbon dioxide (CO2) devices are commonly-used, efficient laser systems for aggressive skin resurfacing procedures. The devices each have different adjustable parameters (density, spot size, number of pulses, pattern, etc) and utilize variable energy capabilities to tailor individual treatments depending on the skin pathology and goals of treatment. Overall, the consensus has been that multiple-pass erbium treatments needed for efficacious wrinkle reduction had similar downtime and comorbidity to the traditional CO2 treatments. Unfortunately, there were limited data comparing the histological differences and changes throughout the wound-healing process over time between the two treatment methods. Objectives: The authors compare the difference in injury following treatment with five novel fractional ablative laser systems in vivo. Differences in damage pattern, treatment depth, and degree of surrounding cellular injury following treatment with each device at common clinical settings are evaluated in a side-by-side histopathologic comparison. Methods: Prior to planned excisional surgery, the panni of 20 abdominoplasty patients were treated with five novel ablative fractional carbon dioxide or Er:YAG laser systems at various clinical parameters, in accordance with the manufacturers' treatment guidelines. After tissue removal two to four hours later, the skin was biopsied and processed for histopathologic evaluation. Specimens were stained with hematoxylin and eosin, along with a terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay, to highlight the degree of irreversible cellular injury. Results: The acute damage profile differed between the fractional Er:YAG and CO2 devices with respect to depth of penetration and extension of coagulation surrounding the microcolumns. The damage pattern was dependent on the parameters set with each device (eg, fluence, pulses, density, pulse width). The TUNEL-stained sections demonstrated more collateral cellular injury surrounding the ablated columns with the CO2 devices than with the Er:YAG systems. Conclusions: Following treatment with the fractional Er:YAG and CO2 devices, deep tissue injury with various coagulative and ablative properties was observed, and it was confirmed that carbon dioxide and erbium devices result in different patterns of injury. As such, each may be better suited for different clinical situations. It is important for practitioners to understand the limitations of a specific device, as well as the tissue injury following a given treatment pattern or protocol, to appropriately tailor their treatment algorithm for a given patient. This extensive histopathologic evaluation of the acute characterization of injury across devices is helpful in clarifying the differences/similarities in laser-tissue interaction following treatment in an in vivo human model.

KW - ablative

KW - fractional

KW - histology

KW - injury

KW - laser

UR - http://www.scopus.com/inward/record.url?scp=77955043743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955043743&partnerID=8YFLogxK

U2 - 10.1177/1090820X10373060

DO - 10.1177/1090820X10373060

M3 - Article

C2 - 20601578

AN - SCOPUS:77955043743

VL - 30

SP - 457

EP - 464

JO - Aesthetic Surgery Journal

JF - Aesthetic Surgery Journal

SN - 1090-820X

IS - 3

ER -